| Dr Anthony James Koehler, MD | |
|
510 S South St, Mount Airy, NC 27030-4422 | |
| (336) 786-4522 | |
| (335) 789-3025 |
| Full Name | Dr Anthony James Koehler |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 510 S South St, Mount Airy, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083622419 | NPI | - | NPPES |
| 03085412 | Medicaid | NY | |
| 5922426 | Medicaid | NC | |
| NCA254A | Other | NC | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 251718 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kraemer Women's Care, Llc | 3173696754 | 8 |
News Archive
An exciting X-ray imaging technology has been successfully developed to the point where it is now ready for translation into all kinds of beneficial applications, including potentially life-saving uses in security and healthcare.
It appears that warnings regarding dangers of smoking appear to be having an effect with the UK placed in 22nd position in a world league of highest cancer rates. Figures show that for men, 280 cases per 100,000 people, is 33rd in the world, with France the highest. The rate for British women, however, is 260.5 per 100,000 – the world's 12th highest, with Denmark top. The UK breast cancer rate for women, which is just over 89, ranks 11th.
Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 9 days ago
| Entity Name | Carolina Family Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655722 PECOS PAC ID: 4587557731 Enrollment ID: O20040203000627 |
News Archive
An exciting X-ray imaging technology has been successfully developed to the point where it is now ready for translation into all kinds of beneficial applications, including potentially life-saving uses in security and healthcare.
It appears that warnings regarding dangers of smoking appear to be having an effect with the UK placed in 22nd position in a world league of highest cancer rates. Figures show that for men, 280 cases per 100,000 people, is 33rd in the world, with France the highest. The rate for British women, however, is 260.5 per 100,000 – the world's 12th highest, with Denmark top. The UK breast cancer rate for women, which is just over 89, ranks 11th.
Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 9 days ago
| Entity Name | Kraemer Women's Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124201280 PECOS PAC ID: 3173696754 Enrollment ID: O20080715000287 |
News Archive
An exciting X-ray imaging technology has been successfully developed to the point where it is now ready for translation into all kinds of beneficial applications, including potentially life-saving uses in security and healthcare.
It appears that warnings regarding dangers of smoking appear to be having an effect with the UK placed in 22nd position in a world league of highest cancer rates. Figures show that for men, 280 cases per 100,000 people, is 33rd in the world, with France the highest. The rate for British women, however, is 260.5 per 100,000 – the world's 12th highest, with Denmark top. The UK breast cancer rate for women, which is just over 89, ranks 11th.
Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 9 days ago
| Entity Name | Obhg South Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538457361 PECOS PAC ID: 7012182504 Enrollment ID: O20111212000681 |
News Archive
An exciting X-ray imaging technology has been successfully developed to the point where it is now ready for translation into all kinds of beneficial applications, including potentially life-saving uses in security and healthcare.
It appears that warnings regarding dangers of smoking appear to be having an effect with the UK placed in 22nd position in a world league of highest cancer rates. Figures show that for men, 280 cases per 100,000 people, is 33rd in the world, with France the highest. The rate for British women, however, is 260.5 per 100,000 – the world's 12th highest, with Denmark top. The UK breast cancer rate for women, which is just over 89, ranks 11th.
Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony James Koehler, MD Po Box 1267, Mount Airy, NC 27030-1267 Ph: (336) 786-4522 | Dr Anthony James Koehler, MD 510 S South St, Mount Airy, NC 27030-4422 Ph: (336) 786-4522 |
News Archive
An exciting X-ray imaging technology has been successfully developed to the point where it is now ready for translation into all kinds of beneficial applications, including potentially life-saving uses in security and healthcare.
It appears that warnings regarding dangers of smoking appear to be having an effect with the UK placed in 22nd position in a world league of highest cancer rates. Figures show that for men, 280 cases per 100,000 people, is 33rd in the world, with France the highest. The rate for British women, however, is 260.5 per 100,000 – the world's 12th highest, with Denmark top. The UK breast cancer rate for women, which is just over 89, ranks 11th.
Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 9 days ago
Dr. Henry Frederick Gregor, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 510 S South St, Mount Airy, NC 27030 Phone: 336-786-4522 Fax: 336-789-3025 | |
Dr. Druery R Devore, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 510 S South St, Mount Airy, NC 27030 Phone: 336-786-4522 Fax: 336-789-3025 | |
Dr. Kenneth D Gitt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 510 S South St, Mount Airy, NC 27030 Phone: 336-786-4522 Fax: 336-789-3025 | |
Virginia Taylor Floyd, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 510 S South St, Mount Airy, NC 27030 Phone: 336-786-4522 Fax: 336-789-3025 |